Animal cloning and the FDA - The risk assessment paradigm under public scrutiny
Article Abstract:
The U.S. Food and Drug Administration (FDA) will be reporting its risk assessment of the safety of diary and meat products derived from animals produced by somatic cell nuclear transfer (SCNT) in the Draft Risk Assessment on Animal Cloning. The analysis has indicated that SCNT does not pose any risks either to animal health or to food consumption.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Priced out of the UK market
Article Abstract:
London-based National Institute for Health and Clinical Excellence (NICE) has asked the drug manufacturers to follow a cost-effective policy but the biotech drugs approved by NICE for U.K. marketing approval, are not cost-effective.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Exploring the role of culture in trust development with service providers. Business (not) as usual: crisis management, service recovery and the vulnerability of organisations
- Abstracts: RNAi-mediated pathways in the nucleus. Synthetic shRNAs as potent RNAi triggers. Silencing the sceptics
- Abstracts: Information distribution. Crisis management services. Celebrities
- Abstracts: The 7 keys to success in PR. Paid placements are here to stay
- Abstracts: The World Wide Web as an industrial marketing communication tool: models for the identification and assessment of opportunities